7/9/2020  8:00:21 AM Chg. +0.5000 Volume Bid11:00:35 AM Ask11:00:35 AM Market Capitalization Dividend Y. P/E Ratio
76.2800EUR +0.66% 1
Turnover: 76.2800
75.6600Bid Size: 500 75.6600Ask Size: 500 22.76 bill.EUR 1.57% 19.26

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Rice Powell
Management board
Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Dr. Olaf Schermeier, Frank Maddux, MD, Harry de Wit, Kent Wanzek, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon, William P. Johnston
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 52.20%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 31 | 7/30/2020 Interim Report 2nd Quarter/6 Months
CW 35 | 8/27/2020 General Shareholder Meeting
CW 44 | 10/29/2020 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
52.20%
Fresenius SE & Co. KGaA
 
30.75%
Thornburg Investment Management Inc.
 
4.96%
BlackRock, Inc.
 
3.12%
Artisan Partners Asset Management Inc.
 
3.02%
FIL Limited
 
2.98%
Norges Bank
 
2.97%